FDA
approval
· 2017-06-08
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a generic fixed-dose combination of irbesartan and hydrochlorothiazide from Hikma Pharmaceuticals USA Inc. through an Original Application (ANDA) f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)